| Code |
| RSCH |
| Title |
| PT. Charlie Hospital Semarang Tbk |
| Address |
|
| Background |
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019. |
| Business cp product |
The Company is engaged in the activities of private hospitals. The Company's hospital is classified as a type D hospital, |
| Subsidiary affiliation |
|
| Commissioners |
| President Commissioner | : Wahyu Fitrianingsih | | | Independent Commissioner | : Roy Octavian | | | | | | Per Sep 30, 2023 | | |
|
| Directors |
| President Director | : Junianto | | | Director | : Sri Mulyaningsih | | | | | | Per Sep 30, 2023 | | |
|
| Underwriter |
| PT. Shinhan Sekuritas Indonesia |
|
| Share registrar |
| PT. Adimitra Jasa Korpora |
|
| Share holders |
| Shareholders | Shares | % | | | | PT Wahyu Agung | 2,105,000,000 | 79.43 | | | | Wahyu Fitrianingsih | 7,500,000 | 0.28 | | | | Junianto | 6,760,000 | 0.26 | | | | Sri Mulyaningsih | 740,000 | 0.03 | | | | Public | 530,000,000 | 20.00 | | | | | | | | | As of Sep 30, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp 11528-Aug-202350530,000,0002,650,000,000
|
| Other infos |
Value of Initial Public Offering : total of IDR 60,950,000,000Public Offering Period: 22 ? 24 August 2023 |
| Created date |
| 2024-03-26 13:23:02 |
| Revised date |
| 2024-03-26 15:50:38 |
| Finance |
| PT. Charlie Hospital Semarang Tbk |
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|